Warrior Met Coal, Inc. stands strong with low-cost production, a robust balance sheet, and the promising Blue Creek project.
In a report released on April 1, Sam Crittenden from RBC Capital maintained a Hold rating on Warrior Met Coal (HCC – Research Report), with a ...
Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...
Warrior Met Coal, Inc.'s ( NYSE:HCC ) investors are due to receive a payment of $0.08 per share on 3rd of March. This... Despite a challenging market environment, Warrior Met Coal Inc (HCC ...
Biopharma makes the NASDAQ top percentage gainers list today on news, currently trading at $2.9008,, up 0.8108.gaining ...
By Francis Page, Jr. Click here for updates on this story April 3, 2025 (Houston Style Magazine) -- In a bold step toward ...
KLP Kapitalforvaltning AS acquired a new stake in shares of Warrior Met Coal, Inc. (NYSE:HCC – Free Report) in the fourth ...
Welsh red meat promotion body Hybu Cig Cymru (HCC) has announced it is raising its levies from 1 April, in line with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results